OHare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M (2007) Age affects outcomes in chronic kidney disease
However, there were five disproportional signals that were not covered on the label that were detected for liraglutide (gastroesophageal reflux disease, gastritis, bezoar, breath odor, and intra-abdominal hematoma), one for dulaglutide (duodenogastric reflux), and three for semaglutide (breath odor, pancreatic failure, and mesenteric panniculitis)
Frequently Asked Questions How much more HbA1c reduction does the combination offer over either drug alone
The two co-primary outcomes were change in kidney oxygenation and change in arterial stiffness